Efficacy of lisinopril in migraine prophylaxis - An open label study

European Journal of Neurology

Volumn 14, Issue 6, 2007, Pages 701-703

  Schuh Hofer, S ^a,b,c   Flach, U ^c   Meisel, A ^c   Israel, H ^c   Reuter, U ^c   Arnold, G ^c,d  

^a UNIVERSITY OF TÜBINGEN   (Germany)

^b UNIVERSITY HOSPITAL TÜBINGEN   (Germany)

^c CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^d Department of Neurology   (Germany)

Author keywords

Angiotensin converting enzyme; Lisinopril; Migraine; Prophylaxis

Indexed keywords

ANGIOTENSIN II ANTAGONIST; ANTIRHEUMATIC AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; ERGOTAMINE DERIVATIVE; LISINOPRIL; TRIPTAN DERIVATIVE;

ADULT; ARTICLE; CHEMOPROPHYLAXIS; CLINICAL ARTICLE; CLINICAL TRIAL; COMPARATIVE STUDY; COUGHING; DISEASE DURATION; DIZZINESS; DRUG EFFICACY; DRUG TREATMENT FAILURE; DRUG WITHDRAWAL; FEMALE; HUMAN; HYPERTENSION; LOW DRUG DOSE; MALE; MIGRAINE; MIGRAINE AURA; OPEN STUDY; PAIN ASSESSMENT; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH PAIN; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADULT; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; FEMALE; HUMANS; HYPERTENSION; LISINOPRIL; MALE; MIGRAINE DISORDERS; TIME FACTORS; TREATMENT OUTCOME;

EID: 34249820820     PISSN: 13515101     EISSN: 14681331     Source Type: Journal    
DOI: 10.1111/j.1468-1331.2007.01764.x     Document Type: Article

References (9)

1. Tronvik E, Stovner LJ, Schrader H, Bovim G. Involvement of the renin-angiotensin system in migraine. Journal of Hypertension Supplement 2006 24 (Suppl. 1 S139 S143.
2. Schrader H, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with angiotensin converting enzyme inhibitor (lisinopril): randomised, placebo controlled, crossover study. BMJ 2001 322 : 19 22.
3. Bender WI. ACE inhibitors for prophylaxis of migraine headaches. Headache 1995 35 : 470 471.
4. Tronvik E, Stovner LJ, Helde G, Sand T, Bovim G. Prophylactic treatment of migraine with an angiotensin II receptor blocker. JAMA 2003 289 : 65 69.
5. Headache Classification Committee of the International Headache Society. Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 1988 8 (Suppl. 7 35 38.
6. Headache Classification Subcommittee of the International Headache Society. The International Classification of Headache Disorders, 2nd edn. Cephalalgia 2004 24 (Suppl. 1 9 160.
7. Diener HC, Hartung E, Chrubasik J, et al. A comparative study of oral acetylsalicylic acid and metoprolol fort he prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study. Cephalalgia 2001 21 : 120 128.
8. Monastruc P, Dang-Tran L, Carvajal A, Rastin M, Monastruc J-L. Naloxone reverses the effects of enalapril and enalaprilic acid on the pressure responses to afferent vagal stimulation. Neuropeptides 1985 6 : 537 542.
9. Paterna S, Di Pasquale P, D'Angelo A, et al. Angiotensin-converting enzyme gene deletion polymorphism determines an increase in frequency of migraine attacks in patients suffering from migraine without aura. European Neurology 2000 43 : 133 136.